Ronald Asbury Andrews, Chief Executive Officer at OncoCyte Corp (OCX), bought 40,000 shares at $1.35 ($54K) on 2020-08-03, disclosed to the SEC on 2020-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCX | BUY | 2021-03-22 | $53K | — | Filing → |
| OCX | BUY | 2020-04-01 | $42.7M | — | Filing → |
| OCX | BUY | 2020-04-01 | $208K | — | Filing → |